文献速递内脏/肾动脉与血管畸形

急性肠系膜上动脉闭塞的选择性微创策略

Selective minimally invasive strategy for acute superior mesenteric artery obstruction.
PubMed 文献 · J Vasc Surg · 2025-01-21

这项前瞻性单臂试验于2020至2023年纳入42例急性肠系膜上动脉闭塞患者,依据术前影像、体征和实验室指标分流至开腹取栓、腹腔镜联合血管内治疗或单纯血管内治疗。30天无慢性肠衰竭生存率为71%(30/42),短期死亡率为11.9%。

要点

  • 30天和2年无慢性肠衰竭生存率分别为71%(30/42)和60%。
  • 短期死亡率(含30天和住院死亡率)为11.9%,作者认为较历史队列改善。
  • 腹腔镜探查患者中43%需中转开腹,40%避免了肠切除。

核心结论

  • 该选择性微创策略用于急性肠系膜缺血管理,显示出较高的30天无慢性肠衰竭生存率和降低的短期死亡率,作者认为该策略在改善急性肠系膜缺血患者结局方面可能有潜在优势。

研究设计与样本

  • 前瞻性单臂试验,2020至2023年开展,纳入因急性肠系膜上动脉闭塞导致急性肠系膜缺血的患者,共42例,达到预定样本量。
  • 根据结合术前影像学表现、体征和实验室标志物的算法,将患者分配至开腹取栓术、腹腔镜联合血管内治疗或单纯血管内治疗三条治疗路径之一。
  • 主要结局为30天无慢性肠衰竭(CIF)生存率。

主要发现

  • 30天和2年无慢性肠衰竭生存率分别为71%(30/42)和60%。
  • 短期死亡率(包括30天死亡率和住院死亡率)为11.9%,原文认为较历史队列改善。
  • 6个月、1年和2年累积死亡率分别为26%、32%和32%。
  • 1年原发通畅率和辅助通畅率分别为90%和97%。
  • 接受腹腔镜探查的患者中43%需中转开腹;接受两次腹腔镜操作的患者(15例)中73%观察到血供改善,40%的病例避免了肠切除。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Acute mesenteric artery obstruction is a severe cause of acute mesenteric ischemia, associated with significant morbidity and mortality. However, there is limited guidance on choosing between traditional and minimally invasive techniques comprehensively. This study introduces a selective, minimally invasive strategy designed to improve the survival and prognosis of patients with acute superior mesenteric artery obstruction. METHODS: In this prospective, single-arm trial conducted between 2020 and 2023, patients with acute mesenteric ischemia due to acute superior mesenteric artery obstruction were enrolled. A total of 42 patients were included, meeting the predetermined sample size. The primary outcome was the 30-day chronic intestinal failure (CIF)-free survival rate. Based on an algorithm incorporating preoperative radiographic findings, physical signs, and laboratory markers, patients were assigned to one of three therapeutic pathways: traditional laparotomy with thrombectomy, laparoscopy combined with endovascular therapy, or endovascular therapy alone. RESULTS: The CIF-free survival rates at 30 days and 2 years were 71% (30/42) and 60%, respectively. Short-term mortality, including 30-day and in-hospital mortality, was 11.9%, indicating an improvement compared with historical cohorts. The cumulative mortality rates at 6 months, 1 year, and 2 years were 26%, 32%, and 32%, respectively. The primary and assisted patency rates at 1 year were 90% and 97%, respectively. Transition to laparotomy was required in 43% of patients undergoing laparoscopic exploration. Improved blood supply was observed in 73% of the patients who underwent two laparoscopic procedures (15 patients), and bowel resection was avoided in 40% of cases. The median durations of hospitalization and intensive care unit stay were 19 days (interquartile range, 11-31 days) and 2 days (interquartile range, 0-6 days), respectively. CONCLUSIONS: This selective, minimally invasive strategy for managing acute mesenteric ischemia demonstrated high 30-day CIF-free survival rates and reduced short-term mortality. These findings suggest the potential advantages of this approach in improving outcomes for patients with acute mesenteric ischemia.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Guo S, Zhao K, Zhu R, et al. Selective minimally invasive strategy for acute superior mesenteric artery obstruction. J Vasc Surg. 2025. PMID: 39848506. doi:10.1016/j.jvs.2025.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。